Papers: 12 Dec 2014 - 19 Dec 2014
Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.
Predictive Value of Baseline Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS) Assessments for Identifying Risk of Prospective Reports of Suicidal Behavior During Research Participation.
High-affinity sigma-1 protein agonist reduces clinical and pathological signs of experimental auto-immune encephalomyelitis.
Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach.
Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activation.
Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis.
Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis.
Modeling the variability in brain morphology and lesion distribution in multiple sclerosis by deep learning.
Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis.
Transcriptional expression of MBP in oligodendrocytes depends on functional syntaxin 4; a potential correlation with autocrine signalling.
Interferon-ß-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab.
Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children.
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles.
Damage to the optic chiasm in myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis mice.
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor.
Using Twitter to investigate opinions about multiple sclerosis treatments: a descriptive, exploratory study.